Recursion Pharmaceuticals, Inc. RXRX Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s other non-current liabilities?
- Recursion Pharmaceuticals, Inc. (RXRX) reported other non-current liabilities of $2.03M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s other non-current liabilities changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s other non-current liabilities decreased by 57.7% year-over-year, from $4.79M to $2.03M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.